Item 7.01 Regulation FD Disclosure.

On January 7, 2022, the Company updated its corporate presentation which it presents or distributes to the investment community and other conferences from time to time. The Company is posting to its website at http://pardesbio.com/ a copy of its current corporate presentation. These slides are attached to this Current Report on Form 8-K as Exhibit 99.1. The Company undertakes no obligation to update, supplement or amend the materials attached hereto as Exhibit 99.1.

The information in this Item 7.01 and Exhibit 99.1 attached hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.

Item 9.01 Financial Statements and Exhibits.





(d) Exhibits



Exhibit
Number                                    Description
99.1        Corporate Presentation

104       Cover Page Interactive Data File (embedded within the Inline XBRL document)




                                       1

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses